Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7495 p355
29 March 2008

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Digital versions of new BNF include extra entries

Digital versions of the latest British National Formulary now include a range of multi-ingredient preparation monographs not available in print.

Historically, the BNF has included only a few monographs for medicinal products with two active ingredients. Monographs for ramipril/felodipine, triamterene/furosemide, co-amilofruse (amiloride/furosemide) and co-tenidone (atenolol/chlortalidone) will be the first of a large number of additional entries in the digital version of BNF 55.

“ This development provides a more accurate representation of the characteristics of these preparations than has hitherto been possible in print, and crucially presents this information in a single location within the publication,” states a leaflet accompanying BNF 55.

The latest edition contains guidance on the community management of emergencies such as anaphylaxis, meningococcal disease and myocardial infarction. This new information is located in the reference pages at the back of the printed BNF and includes doses of drugs to be used for immediate care by community healthcare professionals.

BNF 55 also includes updated advice on the use of adrenaline for anaphylaxis and folic acid for the prevention of neural tube defects, as well as new safety considerations for the use of erythropoietin products.

BNF editors and clinical advisers have reviewed the National Institute for Health and Clinical Excellence guidelines on antimicrobial prophylaxis against infective endocarditis for adults and children undergoing interventional procedures. In line with these guidelines, the BNF now states that antimicrobial prophylaxis is no longer recommended for the prevention of endocarditis for patients having dental and non-dental procedures. Prophylaxis may expose patients to the adverse effects of antimicrobials when the evidence of benefit has not been proven.

Also added is the latest advice on INR (international normalised ratio) monitoring for anticoagulated patients who require dental surgery.

BNF newsletter
Healthcare professionals wishing to be updated with the latest changes affecting clinical practice can sign up to receive joint newsletters from the BNF and BNF for Children. The newsletters, to be issued several times a year, will include:

• details of significant updates
• tips for using the BNF and BNFC effectively
• latest developments on BNF and BNFC publications
• links to case studies and examples of prescribing excellence.


Back to Top


©The Pharmaceutical Journal